77 related articles for article (PubMed ID: 10473924)
1. On the inhibitory activities of a new boron compound and ultrasound against the mouse ascites tumour.
Sur P; Ghosh P; Bag SP; Sur B; Chatterjee SN
Chemotherapy; 1999; 45(5):360-9. PubMed ID: 10473924
[TBL] [Abstract][Full Text] [Related]
2. A new boron compound (guanidine biboric acid adduct) as an antitumour agent against Ehrlich ascites carcinoma in mice.
Ghosh P; Sur B; Bag SP; Sur P
Tumour Biol; 1999; 20(1):44-51. PubMed ID: 9858874
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of antitumor effects of a new boron compound combined with ultrasound on the mouse ascites tumor.
Ghosh P; Sur P; Bag SP
Med Chem; 2012 Nov; 8(6):1026-31. PubMed ID: 22779757
[TBL] [Abstract][Full Text] [Related]
4. On the possible use of a new boron compound, hydroxysalicylhydroxamato boron(III), and ultrasound in the treatment of female mice bearing the Ehrlich ascites carcinoma cells.
Ghosh P; Sur P; Bag SP; Sur B; Chatterjee SN
Neoplasma; 1998; 45(6):384-8. PubMed ID: 10210114
[TBL] [Abstract][Full Text] [Related]
5. Antitumor properties of boron complexes with hydroxy biguanide and salicyl hydroxamic acid against Ehrlich ascites carcinoma.
Ghosh P; Bag SP; Sur B; Sur P
Neoplasma; 1998; 45(2):68-72. PubMed ID: 9687884
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of antitumor effects of 5-fluorouracil combined with ultrasound on Ehrlich ascites tumor in vivo.
Mohamed MM; Mohamed MA; Fikry NM
Ultrasound Med Biol; 2003 Nov; 29(11):1635-43. PubMed ID: 14654158
[TBL] [Abstract][Full Text] [Related]
7. Antineoplastic effect of new boron compounds against leukemic cell lines and cells from leukemic patients.
Murmu N; Ghosh P; Gomes A; Mitra S; Das M; Besra SE; Majumdar J; Bhattacharya S; Sur P; Vedasiromoni JR
J Exp Clin Cancer Res; 2002 Sep; 21(3):351-6. PubMed ID: 12385577
[TBL] [Abstract][Full Text] [Related]
8. Boron compounds against human leukemic cells.
Murmu N; Mitra S; Das M; Gomes A; Vedasiromoni JR; Ghosh M; Bhattacharya M; Ghosh P; Biswas J; Bhattacharya S; Sur P
J Exp Clin Cancer Res; 2001 Dec; 20(4):511-5. PubMed ID: 11876544
[TBL] [Abstract][Full Text] [Related]
9. Prevention of biochemical changes in gamma-irradiated rats by some metal complexes.
Abou-Seif MA; El-Naggar MM; El-Far M; Ramadan M; Salah N
Clin Chem Lab Med; 2003 Jul; 41(7):926-33. PubMed ID: 12940520
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of toxicity of cypenhymustine, a new anticancer compound, in mice.
Sadhu U; Ghosh M; Bhattacharya S; Dutta S; Das H; Sanyal U
Cancer Lett; 1994 Sep; 85(1):65-72. PubMed ID: 7923104
[TBL] [Abstract][Full Text] [Related]
11. Antitumour activities of copper-ATP complex on transplantable murine lymphoma.
Nayak KK; Maity P; Bhattacharyya R; Chatterjee M
Pharmacology; 1990; 41(6):350-6. PubMed ID: 2096396
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of anticancer activity of Cleome gynandra on Ehrlich's Ascites Carcinoma treated mice.
Bala A; Kar B; Haldar PK; Mazumder UK; Bera S
J Ethnopharmacol; 2010 May; 129(1):131-4. PubMed ID: 20307641
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of anti-tumor effects of 5-fluorouracil on hepatocellular carcinoma by low-intensity ultrasound.
Hu Z; Lv G; Li Y; Li E; Li H; Zhou Q; Yang B; Cao W
J Exp Clin Cancer Res; 2016 Apr; 35():71. PubMed ID: 27102814
[TBL] [Abstract][Full Text] [Related]
14. Chloroaceto hydroxamic acid as antitumor agent against Ehrlich ascites carcinoma in mice.
Sur P; Bag SP; Sur B; Khanam JA
Neoplasma; 1997; 44(3):197-201. PubMed ID: 9372863
[TBL] [Abstract][Full Text] [Related]
15. Antineoplastic activity of N-(2-hydroxybenzylidene)2'-hydroxyphenylimine aqua nickel(II) complex [NI(H₂O)HHP] on ehrlich ascites carcinoma (EAC) in Swiss albino mice.
Hossain IA; Khanam JA; Jesmin M; Ali MM
Exp Toxicol Pathol; 2016 Jan; 68(1):15-25. PubMed ID: 26404919
[TBL] [Abstract][Full Text] [Related]
16. Anti-neoplastic activities of Sepia officinalis ink and Coelatura aegyptiaca extracts against Ehrlich ascites carcinoma in Swiss albino mice.
Soliman AM; Fahmy SR; El-Abied SA
Int J Clin Exp Pathol; 2015; 8(4):3543-55. PubMed ID: 26097537
[TBL] [Abstract][Full Text] [Related]
17. Antitumour activity of Terminalia arjuna leaf against Ehrlich ascites carcinoma in mice.
Biswas M; Bhattacharya S; Ghosh AK; Kumar RB; Bera S; Gupta M; Haldar PK
Nat Prod Res; 2012; 26(12):1141-4. PubMed ID: 22017259
[TBL] [Abstract][Full Text] [Related]
18. [Effect of antineoplastic agents on the activity and molecular heterogeneity of lysosomal hydrolases in Ehrlich ascites tumor].
Filov VA; Tret'iakov AV; Riazanov EM
Dokl Akad Nauk SSSR; 1974 Aug; 217(4):961-4. PubMed ID: 4211407
[No Abstract] [Full Text] [Related]
19. Toxicity, pathological effects, and antineoplastic activity of a non-toxic dose of 5-fluorouracil in combination with methotrexate.
Robbins TJ; Bowen D
Anticancer Res; 1988; 8(1):43-9. PubMed ID: 3358639
[TBL] [Abstract][Full Text] [Related]
20. Development of novel 5-fluorouracil carrier erythrocyte with pharmacokinetics and potent antitumor activity in mice bearing malignant ascites.
Wang GP; Guan YS; Jin XR; Jiang SS; Lu ZJ; Wu Y; Li Y; Li M; Luo F
J Gastroenterol Hepatol; 2010 May; 25(5):985-90. PubMed ID: 20546454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
